{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T21:34:29Z","timestamp":1791408869831,"version":"4.3.3"},"reference-count":8,"publisher":"American Society of Hematology","issue":"23","license":[{"start":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T00:00:00Z","timestamp":1727654400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,10]]},"DOI":"10.1182\/bloodadvances.2024013453","type":"journal-article","created":{"date-parts":[[2024,9,30]],"date-time":"2024-09-30T20:56:02Z","timestamp":1727729762000},"page":"5935-5938","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":4,"title":["Febrile neutropenia in patients with Duffy-null\u2013associated neutrophil counts and multiple myeloma or AL amyloidosis"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1549-6419","authenticated-orcid":false,"given":"Maya","family":"Abdallah","sequence":"first","affiliation":[{"name":"1Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3924-2678","authenticated-orcid":false,"given":"Frances","family":"Arters","sequence":"additional","affiliation":[{"name":"1Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3269-1462","authenticated-orcid":false,"given":"Jasmine","family":"Patel","sequence":"additional","affiliation":[{"name":"1Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2601-0667","authenticated-orcid":false,"given":"Camille","family":"Edwards","sequence":"additional","affiliation":[{"name":"1Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Lerner","sequence":"additional","affiliation":[{"name":"1Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Petrocca","sequence":"additional","affiliation":[{"name":"1Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaux","family":"Dockerty","sequence":"additional","affiliation":[{"name":"1Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Fuller","sequence":"additional","affiliation":[{"name":"1Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Godfrey","sequence":"additional","affiliation":[{"name":"1Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1638-4873","authenticated-orcid":false,"given":"Andrew","family":"Staron","sequence":"additional","affiliation":[{"name":"1Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6307-2445","authenticated-orcid":false,"given":"Vaishali","family":"Sanchorawala","sequence":"additional","affiliation":[{"name":"1Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA"},{"name":"2Amyloidosis Center and Section of Hematology and Medical Oncology, Boston University School of Medicine and Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Mark","family":"Sloan","sequence":"additional","affiliation":[{"name":"1Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4565-7618","authenticated-orcid":false,"given":"Kimberly","family":"Bertrand","sequence":"additional","affiliation":[{"name":"3Slone Epidemiology Center, Department of Medicine, Chobanian & Avedisian School of Medicine, Boston University, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6198-3405","authenticated-orcid":false,"given":"Raphael","family":"Szalat","sequence":"additional","affiliation":[{"name":"1Section of Hematology & Medical Oncology, Boston University Chobanian & Avedisian School of Medicine and Boston Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"issue":"3","key":"2024121014464716700_bib1","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1097\/MPH.0000000000000528","article-title":"Identification and clinical characterization of children with benign ethnic neutropenia","volume":"38","author":"Ortiz","year":"2016","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"1","key":"2024121014464716700_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood.2020008600","article-title":"When non-Whiteness becomes a condition","volume":"137","author":"Merz","year":"2021","journal-title":"Blood"},{"issue":"3","key":"2024121014464716700_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1182\/bloodadvances.2022007679","article-title":"Absolute neutrophil count by Duffy status among healthy Black and African American adults","volume":"7","author":"Merz","year":"2023","journal-title":"Blood Adv"},{"key":"2024121014464716700_bib4","unstructured":"What is a \u201cnormal\u201d neutrophil count? The Duffy red cell antigen, ancestry, genetics and evolution. Presented at 65thASH Annual Meeting & Exposition; 11 December 2023; San Diego, CA. Accessed 22 December 2023. https:\/\/ash.confex.com\/ash\/2023\/webprogram\/Session24128.html."},{"key":"2024121014464716700_bib5","volume-title":"Blood Groups and Red Cell Antigens [Internet]","author":"Dean","year":"2005"},{"key":"2024121014464716700_bib6","unstructured":"Common terminology criteria for adverse events (CTCAE). 2017. Accessed 27 June 2024. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5.0.xlsx."},{"issue":"3","key":"2024121014464716700_bib7","first-page":"235","article-title":"Eligibility criteria and enrollment of a diverse racial and ethnic population in multiple myeloma clinical trials","volume":"142","author":"Kanapuru","year":"2023","journal-title":"Blood"},{"key":"2024121014464716700_bib8","unstructured":"FDA\n          . Lenalidomide (Revlimid). Accessed 25 May 2024. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/lenalidomide-revlimid."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/23\/5935\/2344950\/blooda_adv-2024-013453-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/23\/5935\/2344950\/blooda_adv-2024-013453-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T14:46:58Z","timestamp":1733842018000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/23\/5935\/518011\/Febrile-neutropenia-in-patients-with-Duffy-null"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":8,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024013453","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}